This inventor holds 3 USPTO granted patents. Top assignees: Riken Corporation, Institute of Biotechnology Applied to Soil Eumycetes, Other. Active years: 2004-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 890 
1 out of 1 
1 out of 834,513 Years Active: 2004-2009
Title: Susumu Kanazawa: Innovator in Antitumor and Anti-inflammatory Compounds
Introduction
Susumu Kanazawa is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with antitumor and anti-inflammatory properties. With a total of 3 patents to his name, Kanazawa's work has the potential to impact therapeutic strategies for various diseases.
Latest Patents
One of Kanazawa's latest patents is focused on a substance that exhibits antitumor and anti-inflammatory activity. This compound, represented by a specific formula, demonstrates excellent antitumor activity and angiogenesis inhibitory action under low oxygen conditions. It is designed to be used in medicaments such as antitumor agents and anti-inflammatory agents, where the compound or its physiologically acceptable salt serves as the active ingredient.
Another significant patent is for the PKB-3564 substance, which possesses neovascularization inhibitory activity. This compound is characterized by a complex formula where various groups can represent different chemical structures. It is useful as an active ingredient in medicaments that have angiogenesis suppressive activity, apoptosis suppressive activity, and cell cycle inhibitory activity.
Career Highlights
Throughout his career, Susumu Kanazawa has worked with Riken Corporation, a leading research institution in Japan. His work at Riken has allowed him to focus on innovative research and development in the field of medicinal compounds.
Collaborations
Kanazawa has collaborated with notable colleagues such as Hiroyuki Osada and Hideaki Kakeya. These collaborations have likely contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
In summary, Susumu Kanazawa is a distinguished inventor whose work in developing antitumor and anti-inflammatory compounds has the potential to make a significant impact in the medical field. His innovative contributions and collaborations highlight his commitment to advancing medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile